EB
Emily Bodnar HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
78
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
84.6%
Neutral
15.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $30 |
506%
upside
| 1 | +1.3% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $7 |
81%
upside
| 1 | +31% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $38 |
129%
upside
| 1 | +51% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $7 |
83%
upside
| 1 | +20% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $66 |
30%
upside
| 1 | +24% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $32 |
41%
upside
| 1 | +6.3% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $49 |
287%
upside
| 3 | +1% |
0
%
| 26 Feb ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $115 |
0%
upside
| 2 | -1.2% |
0
%
| 23 Feb ‘26 1 month ago |
|
|
|
Buy
Initiated
| $9 |
470%
upside
| 1 | +6.4% |
0
%
| 17 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $65 |
140%
upside
| 2 | -4.7% |
0
%
| 12 Feb ‘26 2 months ago |
|
|
|
Neutral
Downgraded
| $58 |
0%
downside
| 1 | +96% |
0
%
| 20 Jan ‘26 3 months ago |
|